Transforming Cancer Treatment
OncoNOx

Ferdinando Nicoletti, CSO

Professor Ferdinando Nicoletti, MD, is a full Professor of Medical Laboratory Sciences at the University of Catania, Italy. Prof. Nicoletti is a recognized expert in the discovery and development of new drugs for the treatment of autoimmune diseases and cancer. Prof. Nicoletti  serves and has served as an advisor to and collaborator with leading pharmaceutical companies including Amgen, MerckSerono, Leo Pharma, Merck and Pfizer, that led to the clinical development of anti-cancer and immunomodulatory drugs. Prof. Nicoletti has published more than 200 papers in peer reviewed scientific journals, is inventor on 5 patents, and he is in the editorial board of several international journals.